UNSPSC 51381700: Nonsteroidal anti inflammatory acetanilides

Nonsteroidal anti inflammatory drugs made from compounds based on N-phenylacetamide.

UNSPSC 51381700 Nonsteroidal anti-inflammatory acetanilides is a Class code that does not align with the state and local procurement activity the code is tagged to in recent opportunities. The recent solicitations under this code involve naloxone procurement, direct-to-manufacturer prescription programs, and multi-source generic pharmaceuticals and over-the-counter products—none of which are nonsteroidal anti-inflammatory drugs. This tagging mismatch suggests either a data error in the underlying procurement records or inconsistent application of the code to broader pharmaceutical categories. The actual goods being solicited include emergency overdose-reversal drugs (naloxone), generic multi-source pharmaceuticals across all therapeutic classes, and OTC products distributed through state and local health systems and cooperative purchasing vehicles.

The issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Department of Administration's MMCAP, serving Minnesota, Oregon, and other participating jurisdictions). Recent opportunities span Florida, Texas, and the upper Midwest. Representative solicitations include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023; Texas HHS's RFI on direct-to-manufacturer prescription programs posted April 3, 2026; and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, drawing on three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson) and serving state and local government facilities across multiple states.